Medicaid and dual-eligible contracts fuel growth for the California-based insurer, but also come with upfront implementation costs that will lower its earnings this year, executives said.

DH100 recognizes those companies that have helped make New York the capital of healthcare innovation. Empassion grew its ...

Mark Shepard, a Harvard Kennedy School expert, looks at the crossroads facing the American health insurance system, a patched ...

Officials at Musk-led DOGE were given access to the inner workings of the Centers for Medicare and Medicaid Services (CMS), ...

As the Trump administration eyes reductions to federal spending, the impact of Medicaid work requirements is again a topic in ...

Medicare Advantage plans are popular, but some have limited provider networks, while and others require high cost sharing for ...

Medicare beneficiaries often pay monthly premiums, copays, annual deductibles and prescription drug costs. But what you may ...

Medicaid MCR is forecasted at 89.9% for 2025, with most rate increases already known. Medicare is expected to see a slightly elevated MCR above target due to utilization pressure and suboptimal recent ...

Christopher Boerner; Chairman of the Board, Chief Executive Officer, Chief Operating Officer; Bristol-Myers Squibb Co David Elkins; Executive Vice President, Chief Financial Officer, Member of the ...

Bristol-Myers Squibb (NYSE:BMY) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an earnings ...